• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年皮肌炎患儿的自身抗体:来自印度西北部的单中心经验。

Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.

作者信息

Hussain Altaf, Rawat Amit, Jindal Ankur Kumar, Gupta Anju, Singh Surjit

机构信息

Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.

出版信息

Rheumatol Int. 2017 May;37(5):807-812. doi: 10.1007/s00296-017-3707-4. Epub 2017 Mar 22.

DOI:10.1007/s00296-017-3707-4
PMID:28331982
Abstract

The objective of this study is to determine autoantibody profile in children with juvenile dermatomyositis (JDM). Children who were diagnosed with JDM (either recently diagnosed during the study period or follow-up patients) were included in the study. Autoantibodies were detected with commercially available Immunodot kit. Thirty patients were included in the study. Nine out of thirty patients (30%) were positive for one of the 12 autoantibodies tested. Anti-SRP antibody was most common antibody detected in 3 patients followed by anti-MDA-5 antibody in 2 patients; while anti-Jo1 antibody, anti-TIF1-γ antibody, anti-Mi-2 antibody, and anti-PM-Scl antibody were positive in 1 patient each. A different disease phenotype was observed with each autoantibody. The patient with anti-Jo1 antibody had a severe systemic disease in the form of interstitial lung disease; patients with anti-MDA-5 antibody and anti-Mi2 antibody had more severe skin disease with mild muscle disease and patients with anti-SRP antibody had significant skin and muscle disease. Anti-TIF1-γ and anti-PM-Scl antibodies were seen in patients with features of overlap syndrome (myositis-scleroderma). Estimation of autoantibodies may serve as an adjunct tool in delineating and defining distinct clinical phenotypes in children diagnosed with juvenile dermatomyositis. They may also help in prognostication.

摘要

本研究的目的是确定青少年皮肌炎(JDM)患儿的自身抗体谱。被诊断为JDM的儿童(在研究期间新近诊断或随访患者)纳入本研究。使用市售免疫斑点试剂盒检测自身抗体。30例患者纳入本研究。30例患者中有9例(30%)对所检测的12种自身抗体中的一种呈阳性。抗SRP抗体是最常见的检测到的抗体,3例患者呈阳性,其次是抗MDA-5抗体,2例患者呈阳性;而抗Jo1抗体、抗TIF1-γ抗体、抗Mi-2抗体和抗PM-Scl抗体各有1例患者呈阳性。每种自身抗体观察到不同的疾病表型。抗Jo1抗体阳性的患者患有以间质性肺病形式出现的严重全身性疾病;抗MDA-5抗体和抗Mi2抗体阳性的患者有更严重的皮肤病伴轻度肌肉病,抗SRP抗体阳性的患者有明显的皮肤和肌肉病。抗TIF1-γ和抗PM-Scl抗体见于有重叠综合征(肌炎-硬皮病)特征的患者。自身抗体的评估可作为一种辅助工具,用于描述和定义诊断为青少年皮肌炎的儿童的不同临床表型。它们也可能有助于预后判断。

相似文献

1
Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.青少年皮肌炎患儿的自身抗体:来自印度西北部的单中心经验。
Rheumatol Int. 2017 May;37(5):807-812. doi: 10.1007/s00296-017-3707-4. Epub 2017 Mar 22.
2
Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.印度炎性肌病患者的肌炎特异性和肌炎相关性自身抗体
Rheumatol Int. 2016 Jul;36(7):935-43. doi: 10.1007/s00296-016-3494-3. Epub 2016 May 14.
3
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.皮肌炎中的特异性自身抗体:区分不同临床亚组的有用工具。
Arch Dermatol Res. 2017 Mar;309(2):87-95. doi: 10.1007/s00403-016-1704-1. Epub 2016 Dec 7.
4
Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.抗TIF1-α抗体阳性皮肌炎患者的临床特征与共存的皮肌炎特异性自身抗体以及抗TIF1-γ或抗Mi-2自身抗体密切相关。
Rheumatology (Oxford). 2012 Aug;51(8):1508-13. doi: 10.1093/rheumatology/kes073. Epub 2012 Apr 25.
5
Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups.青少年皮肌炎自身抗体亚组中的不同组织损伤模式。
Acta Neuropathol Commun. 2020 Aug 5;8(1):125. doi: 10.1186/s40478-020-01007-3.
6
[Dermatomyositis: new antibody, new classification].[皮肌炎:新抗体,新分类]
Med Sci (Paris). 2019 Nov;35 Hors série n° 2:18-23. doi: 10.1051/medsci/2019178. Epub 2019 Dec 20.
7
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.抗 MDA5 自身抗体与北美青少年皮肌炎相关,构成独特表型。
Rheumatology (Oxford). 2021 Apr 6;60(4):1839-1849. doi: 10.1093/rheumatology/keaa429.
8
Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.特发性炎性肌病特异性自身抗体分类的青少年皮肌炎临床亚型:日本单中心经验。
Mod Rheumatol. 2019 Sep;29(5):802-807. doi: 10.1080/14397595.2018.1511025. Epub 2018 Sep 10.
9
Autoantibodies in polymyositis and dermatomyositis.多发性肌炎和皮肌炎中的自身抗体。
Curr Rheumatol Rep. 2013 Jun;15(6):335. doi: 10.1007/s11926-013-0335-1.
10
The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.在皮肌炎患者的肌肉活检中,个体组织病理学特征的患病率因自身抗体状态而异。
J Rheumatol. 2015 Aug;42(8):1448-54.

引用本文的文献

1
Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis.基于高分辨率计算机断层扫描(HRCT)的影像组学在预测青少年皮肌炎间质性肺疾病中的应用。
BMC Pediatr. 2025 Aug 2;25(1):589. doi: 10.1186/s12887-025-05968-z.
2
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.抗 SAE 抗体相关儿童皮肌炎伴假性血管性水肿 1 例报告
Pediatr Rheumatol Online J. 2024 May 21;22(1):57. doi: 10.1186/s12969-023-00921-9.
3
Biologic drugs in the treatment of juvenile dermatomyositis: a literature review.

本文引用的文献

1
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.重新定义皮肌炎:一种新诊断标准的描述,该标准可区分单纯皮肌炎与具有皮肌炎特征的重叠性肌炎。
Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222.
2
Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.青少年皮肌炎中的抗MDA5自身抗体可识别一种独特的临床表型:一项前瞻性队列研究。
Arthritis Res Ther. 2014 Jul 2;16(4):R138. doi: 10.1186/ar4600.
3
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
生物制剂治疗幼年皮肌炎:文献综述。
Clin Rheumatol. 2024 Feb;43(2):591-602. doi: 10.1007/s10067-023-06740-3. Epub 2023 Aug 16.
4
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes.近十年儿童皮肌炎的研究进展:从分类到结局。
Rheum Dis Clin North Am. 2021 Nov;47(4):669-690. doi: 10.1016/j.rdc.2021.07.003. Epub 2021 Sep 2.
5
Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review.地理纬度仍是某些肌炎自身抗体流行的重要因素:系统评价。
Front Immunol. 2021 Apr 22;12:672008. doi: 10.3389/fimmu.2021.672008. eCollection 2021.
6
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry.理解和管理抗 MDA5 皮肌炎,包括潜在的 COVID-19 模拟。
Rheumatol Int. 2021 Jun;41(6):1021-1036. doi: 10.1007/s00296-021-04819-1. Epub 2021 Mar 27.
7
What is New in Idiopathic Inflammatory Myopathies: Mechanisms and Therapies.特发性炎性肌病的新进展:机制与治疗
Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):458-467. doi: 10.4103/aian.AIAN_400_19. Epub 2020 Apr 13.
8
Auto-antibody evaluation in idiopathic interstitial pneumonia and worse survival of patients with Ro52/TRIM21auto-antibody.特发性间质性肺炎中的自身抗体评估以及Ro52/TRIM21自身抗体患者较差的生存率。
J Clin Biochem Nutr. 2020 Sep;67(2):199-205. doi: 10.3164/jcbn.20-5. Epub 2020 May 15.
9
Inverse Gottron papules in juvenile dermatomyositis: an under recognized clinical entity.幼年型皮肌炎中的反转 Gottron 丘疹:一种认识不足的临床实体。
Rheumatol Int. 2018 Jun;38(6):1153-1160. doi: 10.1007/s00296-018-4038-9. Epub 2018 May 2.
幼年特发性关节炎分类和治疗的进展。
Rheum Dis Clin North Am. 2013 Nov;39(4):877-904. doi: 10.1016/j.rdc.2013.06.001. Epub 2013 Sep 19.
4
Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry.幼年特发性关节炎和风湿病研究联盟登记处:儿童皮肌炎的临床特征。
Arthritis Care Res (Hoboken). 2014 Mar;66(3):404-10. doi: 10.1002/acr.22142.
5
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.青少年特发性炎性肌病的肌炎自身抗体表型
Medicine (Baltimore). 2013 Jul;92(4):223-243. doi: 10.1097/MD.0b013e31829d08f9.
6
Autoantibodies in polymyositis and dermatomyositis.多发性肌炎和皮肌炎中的自身抗体。
Curr Rheumatol Rep. 2013 Jun;15(6):335. doi: 10.1007/s11926-013-0335-1.
7
Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?成人及青少年皮肌炎:我们目前对血清学亚组和致病机制的理解能否解释其不同的临床特征?
Arthritis Res Ther. 2013 Apr 8;15(2):211. doi: 10.1186/ar4198.
8
Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.抗黑色素瘤分化相关蛋白 5 相关皮肌炎:扩展临床谱。
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1307-15. doi: 10.1002/acr.21992.
9
The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.青少年特发性炎性肌病的临床表型。
Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.
10
Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis.抗 MDA5 抗体、铁蛋白和 IL-18 对评估抗 MDA5 抗体阳性皮肌炎相关间质性肺病的治疗反应有用。
Rheumatology (Oxford). 2012 Sep;51(9):1563-70. doi: 10.1093/rheumatology/kes102. Epub 2012 May 15.